BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Jun 08, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Status

DR Cysteamine cysteamine bitartrate: Phase IIb started

Researchers began an open-label, crossover, U.S. Phase IIb trial evaluating single doses of oral DR Cysteamine vs. Cystagon cysteamine bitartrate from Mylan Inc. (NASDAQ:MYL,...

Read the full 107 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >